Chengxin Liu

5PUBLICATIONS
13CO-AUTHORS
Solid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 30, 2026
Efficacy comparison of first-line treatment regimens for stage IV esophageal squamous cell carcinoma with supraclavicular lymph node metastasis: A study of the oligometastatic subtype.

|Apr 23, 2026
Clinical outcomes of thoracic radiotherapy in combination with chemoimmunotherapy in elderly patients with extensive-stage small cell lung cancer.

|Mar 30, 2026
Induction Serplulimab and Chemotherapy Followed by Chemoradiotherapy for Bulky Unresectable Stage III NSCLC: A Phase II Study (SUCCEED-01).

Chengxin Liu, Yang Du, Dan Han

|Jan 01, 2026
Chemoradioimmunotherapy versus chemoimmunotherapy or chemoradiotherapy in extensive-stage small-cell lung cancer: A retrospective analysis of survival outcomes.

Jinmin Han, Ying Hua, Xue Wu

|Nov 11, 2023
PPIs therapy has a negative impact on the clinical outcomes of advanced SCLC patients treated with PD-L1 inhibitors.

Sisi Zhang, Jing Tian, Xinwei Wang

Pageof 1

Frequent Collaborators

2 joint publications

Wei Huang

1 joint publications

Yang Du

1 joint publications

Dan Han

1 joint publications

Baosheng Li